University Hospital of Jena, Department of Internal Medicine III, Jena, Germany.
Int J Gen Med. 2012;5:241-7. doi: 10.2147/IJGM.S28505. Epub 2012 Mar 13.
Long-term outcomes after participation in a structured diabetes treatment and teaching program (DTTP) for patients with diabetes without insulin use, primarily based upon postprandial urine glucose self-monitoring (UGSM).
A total of 126 patients took part in the DTTP in a university outpatient department in 2004-2005. We re-evaluated 119 (94.4%) at baseline and at 6 months, 12 months, and 24 months. Hemoglobin A(1c) (HbA(1c)) was DCCT adjusted.
HbA(1c) decreased significantly 6 months after education from 7.33% (±1.59%) to 6.89% (±0.98%; P = 0.001 versus baseline) and was maintained for up to 12 months (7.02% ± 1.07%; P = 0.017 versus baseline) as well as up to 24 months (6.96% ± 1.06%; P = 0.005 versus baseline). Weight decreased from 92.5 kg at baseline to 90.3 kg at 24 months (P = 0.014). A total of 36.5% of patients not on insulin therapy preferred UGSM, whereas 23.5% preferred blood glucose monitoring, at 24 months. Glucose control was similar in both groups at 24 months (HbA(1c) UGSM 7.03 versus blood glucose monitoring 6.97%; P = 0.807).
Participation in the DTTP resulted in long-term behavior modification. HbA(1c) of patients without insulin met the target 24 months after the DTTP, irrespective of the type of glucose self-monitoring.
参与基于餐后尿糖自我监测(UGSM)的糖尿病结构化治疗和教学计划(DTTP)的糖尿病患者,其胰岛素治疗方案不发生改变,主要评估长期治疗结局。
2004-2005 年,我们在一所大学的门诊部共招募了 126 名接受 DTTP 的患者。我们在基线时、治疗 6 个月、12 个月和 24 个月时对 119 名患者(94.4%)进行了重新评估。我们采用 DCCT 校正糖化血红蛋白(HbA(1c))。
经过 6 个月的教育,HbA(1c)从基线时的 7.33%(±1.59%)显著下降至 6.89%(±0.98%;P=0.001 与基线相比),并在 12 个月时(7.02%±1.07%;P=0.017 与基线相比)和 24 个月时(6.96%±1.06%;P=0.005 与基线相比)得以维持。体重从基线时的 92.5kg 下降至 24 个月时的 90.3kg(P=0.014)。在 24 个月时,共有 36.5%未接受胰岛素治疗的患者更喜欢 UGSM,而 23.5%更喜欢血糖监测。两组患者在 24 个月时的血糖控制情况相似(UGSM 组 HbA(1c)为 7.03%,血糖监测组为 6.97%;P=0.807)。
参与 DTTP 可实现长期行为改变。接受 DTTP 治疗 24 个月后,未接受胰岛素治疗的患者 HbA(1c)达标,无论选择哪种类型的血糖自我监测方式,其疗效相当。